Involvement of Vitamin D Receptor Gene Polymorphism in Increased Cardiovascular Risk Disease in the Algerian

Assia Galleze1, Fatma Zohra Djaballah-Ider1, Ines Gouaref2

  • 1Department of Cellular and Molecular Biology, Faculty of Biological Sciences, Houari Boumediene University of Sciences and Technology, Algiers 16111, Algeria.

Insights

Vitamin D receptor (VDR) gene variations, specifically the ApaI polymorphism, are linked to cardiovascular diseases (CVDs) and heart failure (HF) risk in Algeria. Lower vitamin D levels correlate with increased cardiovascular risk.

Area of Science:

  • Genetics
  • Endocrinology
  • Cardiology

Background:

  • Cardiovascular diseases (CVDs), including heart failure (HF), represent a significant global health burden.
  • Vitamin D plays a crucial role in cardiovascular system regulation.
  • The vitamin D receptor (VDR) gene is a potential factor in CVD development.

Purpose of the Study:

  • To investigate the association between VDR gene polymorphisms and cardiovascular disorders in the Algerian population.
  • To explore the relationship between VDR genotypes, vitamin D levels, and NT-proBNP in CVD patients.

Main Methods:

  • VDR gene polymorphisms (ApaI) identified using PCR-RFLP.
  • Plasma 25-hydroxyvitamin-D levels measured by chemiluminescent immunoassay.
  • Plasma NT-proBNP levels determined by immunoenzymatic analysis.

Main Results:

  • ApaI VDR gene polymorphism frequencies were significantly higher in CVD patients versus controls.
  • Higher prevalence of AA genotypes and A alleles observed in the CVD group.
  • CVD patients with HF showed similar genotype/allele distributions compared to those without HF.
  • Lower vitamin D levels and higher NT-proBNP levels were associated with VDR rs7975232 genotype in CVD patients.

Conclusions:

  • ApaI polymorphism of the VDR gene and low vitamin D levels may increase cardiovascular risk.
  • The VDR ApaI AA genotype could serve as a novel risk marker for heart failure in the Algerian population.

Related Concept Videos

Role of Skin in Vitamin D Synthesis01:23

Role of Skin in Vitamin D Synthesis

The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
7.5K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
876
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
1.4K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.9K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
319
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
302